Required for US and Japanese stocks. A-shares and HK stocks work without a key.
DeepSeek R1 provides high-quality analysis at very low cost. Serper provides real-time search data for context.
Joyzyme Group Limited, an investment holding company, engages in the research, production, and sale of male fertility in-vitro diagnostic (IVD) reagents in the People's Republic of China. The company provides biological reagents, including male fertility IVD reagents, parasite antibody detection reagents, and Epstein-Barr virus antibody detection reagent; healthcare products and supplements; and auxiliary reproductive supplies and equipment. The company sells its products directly to hospitals and medical institutions, as well as to distributors. The company was formerly known as Huakang Biomedical Holdings Company Limited and changed its name to Joyzyme Group Limited in January 2026. Joyzyme Group Limited was founded in 1992 and is based in Tsim Sha Tsui, Hong Kong.
交易所：HKG。行业板块：Healthcare。细分行业：Drug Manufacturers - Specialty & Generic。最新股价：HK$0.2。本页提供 Joyzyme Group Limited 的 DCF 现金流折现估值、相对估值历史分位、多维财务评分与 AI 辅助分析。
Required for US and Japanese stocks. A-shares and HK stocks work without a key.
DeepSeek R1 provides high-quality analysis at very low cost. Serper provides real-time search data for context.